相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation
Joshua C. Bis et al.
MOLECULAR PSYCHIATRY (2020)
Cerebrospinal fluid progranulin is associated with increased cortical thickness in early stages of Alzheimer's disease
Lucia Batzu et al.
NEUROBIOLOGY OF AGING (2020)
The mutational constraint spectrum quantified from variation in 141,456 humans
Konrad J. Karczewski et al.
NATURE (2020)
Microglial Progranulin: Involvement in Alzheimer's Disease and Neurodegenerative Diseases
Anarmaa Mendsaikhan et al.
CELLS (2019)
Recent Advances in Multi-target Anti-Alzheimer Disease Compounds (2013 Up to the Present)
Ning Wang et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Translating the biology of aging into novel therapeutics for Alzheimer disease
Yuko Hara et al.
NEUROLOGY (2019)
Genetic screen in a large series of patients with primary progressive aphasia
Eliana Marisa Ramos et al.
ALZHEIMERS & DEMENTIA (2019)
Deep whole-genome sequencing of 3 cancer cell lines on 2 sequencing platforms
Kanika Arora et al.
SCIENTIFIC REPORTS (2019)
Religious Orders Study and Rush Memory and Aging Project
David A. Bennett et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration
Irene Piaceri et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Whole genome sequencing of Caribbean Hispanic families with late-onset Alzheimer's disease
Badri N. Vardarajan et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease
Neha S. Raghavan et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
A multi-omic atlas of the human frontal cortex for aging and Alzheimer's disease research
Philip L. De Jager et al.
SCIENTIFIC DATA (2018)
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline
Marc Suárez‐Calvet et al.
EMBO Molecular Medicine (2018)
Alzheimer neuropathology without frontotemporal lobar degeneration hallmarks (TAR DNA-binding protein 43 inclusions) in missense progranulin mutation Cys139Arg
Veronica Redaelli et al.
BRAIN PATHOLOGY (2018)
PGRN Is Associated with Late-Onset Alzheimer's Disease: a Case-Control Replication Study and Meta-analysis
Hui-Min Xu et al.
MOLECULAR NEUROBIOLOGY (2017)
Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype
David M. A. Mann et al.
BRAIN PATHOLOGY (2017)
NIAGADS: The NIA Genetics of Alzheimer's Disease Data Storage Site
Amanda Kuzma et al.
ALZHEIMERS & DEMENTIA (2016)
Progranulin Reduction Is Associated With Increased Tau Phosphorylation in P301L Tau Transgenic Mice
Masato Hosokawa et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
ppcor: An R Package for a Fast Calculation to Semi-partial Correlation Coefficients
Seongho Kim
COMMUNICATIONS FOR STATISTICAL APPLICATIONS AND METHODS (2015)
Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models
S. Sakura Minami et al.
NATURE MEDICINE (2014)
Age-Specific Incidence Rates for Dementia and Alzheimer Disease in NIA-LOAD/NCRAD and EFIGA Families National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA)
Badri N. Vardarajan et al.
JAMA NEUROLOGY (2014)
Disease-related mutations among Caribbean Hispanics with familial dementia
Joseph H. Lee et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2014)
Overview and Findings from the Religious Orders Study
David A. Bennett et al.
Current Alzheimer Research (2013)
Overview and Findings from the Rush Memory and Aging Project
David A. Bennett et al.
Current Alzheimer Research (2013)
Progranulin Mutations as Risk Factors for Alzheimer Disease
David C. Perry et al.
JAMA NEUROLOGY (2013)
Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families
Carlos Cruchaga et al.
PLOS ONE (2012)
Validation of the Spanish Center for Epidemiological Studies Depression and Zung Self-Rating Depression Scales: A Comparative Validation Study
Paulo Ruiz-Grosso et al.
PLOS ONE (2012)
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Adam C. Naj et al.
NATURE GENETICS (2011)
Alzheimer Disease–like Phenotype Associated With the c.154delA Mutation in Progranulin
Brendan J. Kelley et al.
ARCHIVES OF NEUROLOGY (2010)
Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes
Gyungah Jun et al.
ARCHIVES OF NEUROLOGY (2010)
Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models
Sandra Pereson et al.
JOURNAL OF PATHOLOGY (2009)
Increased frequency of learning disability in patients with primary progressive aphasia and their first-degree relatives
Emily Rogalski et al.
ARCHIVES OF NEUROLOGY (2008)
Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia
Rosa Rademakers et al.
HUMAN MOLECULAR GENETICS (2008)
Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia
Odity Mukherjee et al.
HUMAN MUTATION (2008)
Concomitant TAR-DNA-binding in Alzheimer disease and protein 43 pathology is present corticobasal degeneration but not in other tauopathies
Kunihiro Uryu et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2006)
Role of genes and environments for explaining Alzheimer disease
M Gatz et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study
David A. Bennett et al.
NEUROEPIDEMIOLOGY (2006)
The Middelheim Frontality Score: a behavioural assessment scale that discriminates frontotemporal dementia from Alzheimer's disease
PP De Deyn et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2005)
分享论文
